Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
7h
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.
dermatologyadvisor
12h
Pediatric Atopic Dermatitis: Dupilumab Normalizes Inflammatory Biomarkers
Dupilumab decreases general and type 2 inflammatory biomarker levels in children with moderate to severe atopic dermatitis.
Healthcare Asia on MSN
20h
Atopic dermatitis market to reach $16.7b by 2030 across seven major markets
Pharmaceutical firms are urged to capitalise on current trends in AD trials. The atopic dermatitis (AD) market is projected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Secret Service admits failure
Kentucky judge fatally shot
Secret Service probing post
$230 million crypto theft
Body found in SUV
Remains ID'd as KY shooter
Boy kills bear, saves father
Russia threatens retaliation
Whooping cough cases spike
Disney to stop using Slack
Pandas leaving for China
Recalling 449K+ vehicles
Vows to remain in race
$3B for battery projects
Baby powder recalled
Collapse hazard recall
144K+ Mavericks recalled
Stein's ballot bid rejected
MS sheriff's office probe
Feds subpoena Schaeffer
PGA welcomes LIV players
Top Hezbollah leader killed?
In-person voting begins
Raises settlement offer
FDA approves flu vaccine
WI high court to decide
Hand count approved in GA
Sues pharmacy middlemen
Bill to boost security OK'd
House repeals emission rules
Overdose deaths drop in US
1st rabies outbreak in seals
Hiker injured in bear attack
Related topics
Ebglyss
Food and Drug Administration
Feedback